Protara Therapeutics (TARA) Stock Plunges After $75 Million Offering: Latest Trial Data, Analyst Targets and Outlook as of December 5, 2025
Protara Therapeutics shares fell about 21% to $5.44 on December 5 after pricing a $75 million public stock offering at $5.75 per share, increasing the share count by roughly 34%. Trading volume surged to 4.8 million shares, well above recent averages. The company’s market cap stood near $260 million, with institutional holders owning nearly 79%. The offering is expected to close on or about December 8.